Claros Mortgage Trust Earnings Call Shows Painful Progress

Claros Mortgage Trust, Inc. ((CMTG)) has held its Q4 earnings call. Read on for the main highlights of the call.

Claros Mortgage Trust’s latest earnings call struck a cautiously optimistic tone as management highlighted tangible progress in shrinking risk and shoring up liquidity while acknowledging that earnings and credit costs remain under heavy pressure. The message to investors was clear: the balance sheet is healing, but the turnaround is still mid-course and will take time to translate into returns.

Resolution Pace Outruns 2025 Targets

CMTG underscored execution momentum by surpassing its 2025 resolution goal, closing the year with $2.5 billion of unpaid principal balance resolved against a $2.0 billion target. That tally included 11 watchlist loans totaling $1.3 billion, signaling management’s willingness to tackle troubled positions rather than extend and pretend.

Deleveraging Drives a Leaner Balance Sheet

The company emphasized a sharp reduction in leverage, cutting debt by about $1.7 billion in 2025 and a further $300 million year-to-date for roughly $2.0 billion of total deleveraging. As a result, net debt-to-equity improved from 2.4 times at the end of 2024 to 1.9 times at December 31, 2025, strengthening the capital structure.

HPS Term Loan Resets Corporate Maturity Profile

Management detailed a major refinancing, retiring the prior Term Loan B and replacing it with a $500 million senior secured term loan from HPS maturing in January 2030 and priced at SOFR plus 675 basis points. In connection with the facility, the company issued detachable warrants for roughly 7.5 million shares at $4, set at a substantial premium to the late January 2026 stock price.

Liquidity Cushion Edges Higher

Following the refinancing, available liquidity stood at $153 million, up $51 million from the prior year-end and above internal minimum targets. Management indicated that incremental cash will mainly be used to further delever or for other capital allocation decisions, preserving flexibility as the portfolio shrinks.

Deliberate Portfolio Runoff and Turnover

CMTG’s held-for-investment loan portfolio declined to $3.7 billion at December 31, 2025, down from $6.1 billion a year earlier and $4.3 billion at the prior quarter-end. This roughly 39% year-over-year and 14% sequential reduction reflects an intentional strategy to reduce balance sheet size and rotate out of higher-risk credits.

REO Sales and Hotel Performance Support Recoveries

On the real-estate-owned front, the company completed commercial condominiumization of a New York mixed-use asset and sold the office floors plus signage for $67 million of gross proceeds, generally in line with carrying values. CMTG also highlighted that its New York City hotel REO portfolio delivered about 14% year-over-year NOI growth and is currently accretive to earnings.

Early 2026 Resolutions Extend Momentum

The brisk pace of asset resolution continued into early 2026 with $389 million of additional UPB resolved across four loans. These included repayment of a $67 million New York City land loan and a $174 million Salt Lake City multifamily position, along with a Dallas multifamily foreclosure and a Seattle office resolution, showing ongoing portfolio cleanup.

Sharper Strategic Focus and Execution Discipline

Management reiterated a clear playbook centered on resolving watchlist loans, optimizing REO sales, and continuing to delever before considering new lending. The company aims to reach a cleaner, more transparent portfolio and expects to be in a position to evaluate fresh originations toward the end of 2026 if conditions allow.

Pullback From Higher-Risk Property Types

CMTG reported significant reductions in problem sectors, fully exiting stand-alone life science exposure while cutting office exposure from $859 million to $589 million and land from $489 million to $187 million. These moves reflect an active repositioning of the book away from weaker segments where valuations and liquidity remain challenged.

Losses Underscore Ongoing Earnings Strain

Despite balance sheet progress, financial results remained weak with a GAAP net loss of $1.56 per share and a distributable loss of $0.71 per share in the fourth quarter. Distributable earnings before realized gains and losses were just $0.02 per share, underscoring the earnings drag from resolutions, reserves, and a shrinking interest-earning base.

CECL Build Highlights Heightened Credit Risk

Credit provisioning was heavy as the company booked $212 million of CECL expense in the quarter, driven largely by a $283 million increase in specific reserves partly offset by a $62 million reduction in general reserves. Overall CECL reserves on loans rose to $443 million or 10.9% of UPB, up from $308 million and 6.8% a quarter earlier, signaling continued caution on credit outcomes.

Charge-Offs and Write-Downs Realize Losses

The portfolio clean-up translated into realized hits, including a $46 million principal charge-off on a Connecticut office loan in the fourth quarter. The company also cited foreclosures and write-downs such as a Dallas multifamily loan marked down to $37 million of carrying value on a $77 million UPB foreclosure, crystallizing losses but reducing future uncertainty.

Loan Downgrades Reflect Persistent Stress Pockets

Risk ratings moved lower on several positions, including a $220 million luxury hotel loan downgraded to rating 4 and three loans pushed to rating 5. Among the weakest were a $170 million Denver multifamily loan, a $225 million Atlanta office loan nearing maturity, and the Seattle office asset, underscoring that certain markets and asset types remain under pressure.

Net Interest Income Under Pressure

Net interest income for the fourth quarter was about $12.5 million, already reflecting the impact of portfolio runoff and deleveraging. Management cautioned that NII is likely to be lower and volatile in the first half of 2026 as loan balances decline faster than funding costs, creating choppy earnings until the portfolio stabilizes.

Costly New Debt and Dilution Overhang

While the HPS term loan extended the company’s maturity profile, its pricing at SOFR plus 675 basis points underscores the high cost of capital facing the platform today. The detachable warrants tied to the facility also introduce potential equity dilution over time, which investors will need to weigh against the balance sheet benefits.

Stock Trades at a Deep Book Value Discount

Management and analysts acknowledged that CMTG shares continue to trade at a significant discount to book value, reflecting investor skepticism about ultimate recoveries and return potential. The call emphasized that closing this valuation gap will likely be a multi-year effort as the company works back to target hurdle rates and more normalized earnings.

Slow Transaction Markets Cloud Timing

Even as capital markets show signs of improvement, the company suggested overall transaction volumes remain below historical norms. This implies that progress on asset sales and eventual re-deployment into new originations will likely be gradual, with no single catalyst to rapidly re-rate the stock or earnings power.

Guidance: 2026 Remains a Restructuring Year

Looking ahead, management indicated that 2026 will remain centered on asset management, continuing to resolve watchlist loans and work through REO while trimming risky exposures. They highlighted improved leverage, higher liquidity, and growing CECL reserves, but warned that net interest income in the first half will stay pressured, with capital allocation decisions at year-end potentially spanning new originations, further deleveraging, or other options.

Claros Mortgage Trust’s earnings call painted a picture of a lender making real progress in cleaning up its book and strengthening its balance sheet, even as that work weighs on near-term profitability. For investors, the story is one of patience: risk is coming down and liquidity is improving, but meaningful earnings recovery and a re-rating of the stock are likely to unfold only gradually over the next few years.